About Intervacc
Intervacc is a company based in Stockholm (Sweden) founded in 2001.. Intervacc offers products and services including Strangvac Vaccine and Recombinant Protein Vaccines. Intervacc operates in a competitive market with competitors including Merck Animal Health, TARGAN, Genvax Technologies, HIPRA and VitamFero, among others.
- Headquarter Stockholm, Sweden
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Intervacc Ab (Publ)
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intervacc
Intervacc offers a comprehensive portfolio of products and services, including Strangvac Vaccine and Recombinant Protein Vaccines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccine for preventing kvarka in horses
Vaccines targeting animal diseases to reduce antibiotic use
Funding Insights of Intervacc
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Grant - Intervacc | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Intervacc
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Intervacc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intervacc Comparisons
Competitors of Intervacc
Intervacc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, Genvax Technologies, HIPRA and VitamFero, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccine technology is developed and supplied for livestock animals.
|
|
| domain | founded_year | HQ Location |
Automated targeted vaccine systems for livestock and aquaculture are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for animal diseases are developed using mRNA nanoparticles.
|
|
| domain | founded_year | HQ Location |
Vaccines and diagnostic kits for animal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Offers patented immunostimulating vaccines for livestock.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intervacc
Frequently Asked Questions about Intervacc
When was Intervacc founded?
Intervacc was founded in 2001 and raised its 1st funding round 23 years after it was founded.
Where is Intervacc located?
Intervacc is headquartered in Stockholm, Sweden.
What does Intervacc do?
Intervacc was founded in 2001 in Stockholm, Sweden, as a biotechnology firm focused on recombinant protein vaccines for livestock. Operations center on three projects: Strangvac for preventing strangles in horses caused by Streptococcus equi, INV-274 for Streptococcus suis infections in pigs, and a vaccine against Staphylococcus aureus-induced mastitis. Products are distributed through subsidiary Nordvacc AB in the European market, with patents applied for recombinant technologies.
Who are the top competitors of Intervacc?
Intervacc's top competitors include TARGAN, Merck Animal Health and Genvax Technologies.
What products or services does Intervacc offer?
Intervacc offers Strangvac Vaccine and Recombinant Protein Vaccines.